To end the year: breakdown and advice for ARPA-H's healthspan-focused PROSPR call, largely from discussions in @norngroup. The call is very ambitious, a sincere attempt at overcoming several of the biggest barriers for longevity medicine.

A huge thank you to Martin Borch Jensen and Norn Group for this thorough, informative and kind commentary of PROSPR. Below is some additional information for color and clarity.

In March 2024, we hosted our inaugural D.C. Fly-In, bringing together industry leaders, academics, investors, and policymakers. Despite the challenges of navigating a potential government shutdown, we successfully showcased the importance of representing the longevity science

On January 28, 2025, we’re kicking off Nucleate: Inside Aging with a free virtual opening session featuring two pioneering leaders in aging biology and longevity biotech. Register here: lu.ma/ej49cnxn Martin Borch Jensen, @EricVerdin, Buck Institute, Gordian Biotechnology, Norn Group

We're hiring for engineering and scientist positions at Cradle! Team is moving very quickly, on the most impactful + fun problem ever (go 0->1 on new technologies that span neuroscience, applied physics, mol bio, engineering). Apply here - cradle.xyz/careers

If you don’t already subscribe to the BioTech Nation podcast with Dr. Moira Gunn, you will now! The latest episode dropped today, featuring co-founders Francisco LePort and Martin Borch Jensen discussing how Gordian’s high-throughput in vivo screening platform will transform drug discovery

ICYMI, co-founders Francisco LePort and Martin Borch Jensen were guests of Dr. Moira Gunn on the BioTech Nation podcast. It ran on our hometown NPR station KQED and about 200 other NPR affiliates.

It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis

It’s time to legalize supersonic flight and Make America Boom Again 🇺🇸 You can just do things. But to do some things you have to be President Donald J. Trump

1/ Martin Borch Jensen dropped out of academia to solve aging. Now, his company is testing hundreds of aging therapies at once—inside living animals. Come to Vitalist Bay (April 12-13) to hear him live. Here’s why his work is a paradigm shift in longevity research:

Partnerships have been crucial to Mammoth's success, delivering $200M+ in upfront payments. I wrote up the guide I wish someone had given me when I started out. Hope this helps others close the right deal! 🧵 and link:

Check out chief science officer Martin Borch Jensen's post tackling misconceptions about AAV gene therapy only being best suited for rare diseases, and how factors like cost would be very different for common diseases like Parkinson’s, heart failure, and arthritis. The post was also

x.com/i/article/1916…

This news should instill urgency and remind us to ask ‘why not sooner?’. Martin Borch Jensen shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen. gordian.bio/blog/cures-on-…

‘Curing age-related diseases is our North Star’ Francisco LePort #longevity #biotech #drugdevelopment #aging longevity.technology/news/curing-ag…

Our CEO discussed the latest developments at Gordian with Danny Sullivan, including partnering efforts, cures for OA, and vision for the future.

Nicole Verdun, director of the cell and gene therapy office, has been placed on forced out of the FDA statnews.com/2025/06/18/top…

Longevity is an answer to so many of the challenges facing America. → Exploding debt + deficits → Slowing GDP → Declining fertility We go into it in detail here (and details matter here, so it's worth the extra characters). nfx.com/post/longevity… Simplified argument

I recently shared why longevity is one of the most powerful solutions to America’s challenges.  The response has been awesome! It’s exciting to see more people connecting the dots.  Thanks to Longevity Technology for sharing: longevity.technology/news/reimagini…